ReMinded

Grateful that ReMinded has been named one of 10 Companies to Watch for 2026 💪🏽 Our priority has been getting the science and regulatory fundamentals right, and it’s encouraging to see that work recognized.

Building locally in New York has raised the bar for how we execute as a team every day. Appreciative of DHNY for recognizing companies willing to take on the hard, often unglamorous work healthcare requires.

A few weeks ago, our Co-Founder & CEO, Annika Lundström, took the stage at the United Nations to speak on women- and youth-led innovation and leadership in NYC.

At ReMinded, we believe in showing what it really looks like to step into unfamiliar industries, with courage, resilience, and authenticity. Progress doesn’t come without challenge, and that pushing boundaries is simply the cost of entry to creating real change.

💡 In a world where women remain underrepresented in leadership, we’re proud to be building a female-founded, globally diverse MedTech company, proving every day that results matter more than stereotypes.

Thank you to the Permanent Mission of Finland to the UN, Nuorten Agenda 2030, and Jenni Palukka for making this initiative possible, and for bringing together voices that inspire the next generation of innovators. 🙌

Here’s to more leaps of faith, more women leading, and a healthier future for all. 🫡

ReMinded has received approval to initiate our Investigational Device Exemption (IDE) study for our saliva-based cortisol detection test! 🎉

This marks a major milestone in our clinical validation journey toward FDA clearance (anticipated in Q4 2025) and brings us one step closer to transforming how mental health conditions are measured and managed.

Our team is deeply committed to advancing accessible, non-invasive solutions, and this IDE approval validates both the strength of our science and the urgency of our mission.

Stay tuned as we enter this clinical phase and continue driving innovation in mental health care. More updates coming soon.

Reflecting on nearly a year of progress, ReMinded is grateful for the abundant opportunities we’ve had in the U.S. so far. The support and innovation we’ve experienced, particularly in Nashville, have played a pivotal role in our success. We’re thrilled to head to the Frontiers Summit 2025, where our CEO, Annika Lundström, will be part of the Global Biotech Innovation panel, contributing to discussions that are shaping the future of healthcare.

📅 When: February 27-28, 2025
📍 Where: Noah Liff Opera Center, Nashville, TN
Summit Website + Tickets: https://phasecapital.co/frontiers-summit/